Early coronary angiogenesis in response to thyroxine growth characteristics and upregulation of basic fibroblast growth factor

Circulation Research

Volumn 82, Issue 5, 1998, Pages 587-593

  Tomanek, Robert J ^a,b   Doty, Matthew K ^a,b   Sandra, Alexander ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Basic fibroblast growth factor mRNA; Capillary; Cardiac hypertrophy; In situ hybridization; Microcirculation

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; MESSENGER RNA; THYROXINE;

ANGIOGENESIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY; CONTROLLED STUDY; DNA SYNTHESIS; ENDOTHELIUM CELL; GENE EXPRESSION; HEART VENTRICLE HYPERTROPHY; IN SITU HYBRIDIZATION; MALE; MICROCIRCULATION; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RAT;

EID: 0032559767     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.82.5.587     Document Type: Article

References (44)

1. Friberg P. Diastolic characteristics and cardiac energetics of isolated hearts exposed to volume and pressure-overload. Cardiovasc Res. 1988;22: 329-339.
2. Tomanek RJ, Busch TL. Coordinated capillary and myocardial growth in response to thyroxine treatment. Anat Rec. In press.
3. Gay RG, Raya TE, Lancaster LD, Lee RW, Morkin E, Goldman S. Effects of thyroid state on venous compliance and left ventricular performance in rats. Am J Physiol. 1988;254:H81-H88.
4. Craft-Cormney C, Hansen JT. Early ultrastructural changes in the myocardium following thyroxine-induced hypertrophy. Virchows Arch. 1980; 33:267-273.
5. Chilian WM, Wangler RD, Peters KG, Tomanek RJ, Marcus ML. Thyroxine-induced left ventricular hypertrophy in the rat: anatomical and physiological evidence for angiogenesis. Circ Res. 1985;57:591-598.
6. Wachtlova M, Ostadal B, Mares V. Thyroxine-induced cardiomegaly in rats of different age. Physiol Bohemoslov. 1985;34:385-395.
7. Breisch EA, White FC, Hammond HK, Flynn S, Bloor CM. Myocardial characteristics of thyroxine stimulated hypertrophy: a structural and functional study. Basic Res Cardiol. 1989;84:345-358.
8. Mall G, Zimmer G, Baden S, Mattfeldt T. Capillary neoformation in the rat heart: stereological studies on papillary muscles in hypertrophy and physiologic growth. Basic Res Cardiol. 1990;85:531-540.
9. Tomanek RJ, Connell PM, Butters CA, Torry RJ. Compensated coronary microvascular growth in senescent rats with thyroxine-induced cardiac hypertrophy. Am J Physiol. 1995;268:H419-H425.
10. Heron MI, Kolar F, Papousek F, Rakusan K. Early and late effect of neonatal hypo- and hyperthyroidism on coronary capillary geometry and long-term heart function in rat. Cardiovasc Res. 1997;33:230-240.
11. Tomanek RJ, Torry RJ. Growth of the coronary vasculature in hypertrophy: mechanisms and model dependence. Cell Mol Biol Res. 1994;40: 129-136.
12. Freedberg AS, Hamolsky MW. Effects of thyroid hormones on certain nonendocrine organ systems. In: Handbook of Physiology: Endocrinology, Volume III, Thyroid. Washington, DC: American Physiological Society; 1974:435-468.
13. Morkin E, Flink I, Goldman S. Biochemical and physiological effects of thyroid hormone on cardiac performance. Prog Cardiovasc Dis. 1983;25: 435-464.
14. 2 consumption. Circ Res. 1983;52:272-279.
15. Torry RJ, O'Brien DM, Connell PM, Tomanek RJ. Dipyridamole-induced capillary growth in normal and hypertrophic hearts. Am J Physiol. 1992;262:H980-H986.
16. Tomanek RJ, Huang Li, Suvarna PR, O'Brien LC, Ratajska A, Sandra A. Coronary vascularization during development in the rat and its relationship to basic fibroblast growth factor. Cardiovasc Res. 1996;31:E116-E126.
17. Höckel M, Jung W, Vaupel P, Rabes H, Khaledpour C, Wissler JH. Purified monocyte-derived angiogenic substance (angiotropin) induces controlled angiogenesis associated with regulated tissue proliferation in rabbit skin. J Clin Invest. 1988;82:1075-1090.
18. Yanagisawa-Miwa A, Uchida Y, Nakamura F, Tomlaru T, Kido H, Kamijo T, Sugimoto T, Kaji K, Utsuyama M, Kurashima C, Ito H. Salvage of infarcted myocardium of angiogenic action of basic fibroblast growth factor. Science. 1992;257:1401-1403.
19. Unger EF, Banai S, Shou M, Lazarous DF, Jaklitsch MT, Scheinowitz M, Correa R, Klingbeil C, Epstein SE. Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am J Physiol. 1994;266: H1588-H1595.
20. Biro S, Yu Z-X, Fu Y-M, Smale G, Sasse J, Sanchez J, Ferrans VJ, Casscells W. Expression and subcellular distribution of basic fibroblast growth factor are regulated during migration of endothelial cells. Circ Res. 1994;74: 485-494.
21. Ratajska A, Torry RJ, Kitten GT, Kolker SJ, Tomanek RJ. Modulation of cell migration and vessel formation by vascular endothelial growth factor and basic fibroblast growth factor in cultured embryonic hearts. Dev Dyn. 1995;203:399-407.
22. Killingsworth MC. Angiogenesis in early choroidal neovascularization secondary to age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 1995;233:313-323.
23. Tomanek RJ, Butters CA, Zimmerman MB. Initiation of cardiac hypertrophy in response to thyroxine is not limited by age. Am J Physiol. 1993;264:H1041-H1047.
24. Lojda Z. Studies on dipepidyl(amino)peptidase IV (glycyl-proline naphthylamidase), I: blood vessels. Histochemistry. 1979:59:153-166.
25. Shimasaki S, Emoto N, Kobu A, Mercado M, Shibata F, Cooksey K, Baird A, Ling N. Complementary DNA cloning and sequencing of rat ovarian basic fibroblast growth factor and tissue distribution study of its mRNA. Biochem Biophys Res Commun. 1988;157:256-263.
26. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
27. Klein I, Hong C. Effects of thyroid hormone on cardiac size and myosin content of the heterotropically transplanted rat heart. J Clin Invest. 1990; 77:1694-1698.
28. Rongish BJ, Torry RJ, Tomanek RJ. Coronary neovascularization of embryonic rat hearts cultured in oculo is independent of thyroid hormones. Am J Physiol. 1995;268:H811-H816.
29. Tomanek RJ, Barlow PA, Connell PM, Chen Y, Torry RJ. Effects of hypothyroidism and hypertension on myocardial perfusion and vascularity in rabbits. Am J Physiol. 1993;265:H1638-H1644.
30. Mall G, Schikora I, Mattfeldt T, Bodle R. Dipyridamole-induced neoformation of capillaries in the rat heart. Lab Invest. 1987;57:86-93.
31. Ziada A, Hudlicka O, Tyler K, Wright A. The effect of long-term vasodilation on capillary growth and performance in rabbit heart and skeletal muscle. Cardiovasc Res. 1984;18:724-732.
32. Meininger CJ, Schikora I, Mattfeldt T, Granger HJ. Mechanisms leading to adenosine-stimulated proliferation of microvascular endothelial cells. Am J Physiol. 1990;258:H198-H206.
33. Folkman J, Moscona A. Role of cell shape in growth control. Nature. 1978;273:245-249.
34. Davies PF, Remuzi A, Gordon ES, Dewey F, Gimbrone MA. Turbulent fluid stress induces vascular endothelial cell turnover in vitro. Proc Natl Acad Sci U S A. 1986;83:2114-2117.
35. Chen Y, Torry RJ, Baumbach GL, Tomanek RJ. Proportional arteriolar growth accompanies cardiac hypertrophy induced by volume overload. Am J Physiol. 1994;267:H2132-H2137.
36. Batra S, Rakusan K. Capillary network geometry during postnatal growth. Am J Physiol. 1993;262:H635-H640.
37. Kohl A, Volk HD, Buntrack P, Kohl G, Diamantstein T, von Baehr. The role of dipeptidylpeptidase IV positive T cells in wound healing and angiogenesis. Agents Actions. 1991;32:125-127.
38. Burgess WH, Maciag T. The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem. 1989;58:575-606.
39. Lazarous DF, Scheinowitz M, Shou M, Hodge E, Rajanayagam MAS, Hunsberger S, Robinson WG Jr, Stiber JA, Correa R, Epstein SE, Unger EF. Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart. Circulation. 1995;91: 145-153.
40. Padua RR, Sethi R, Dhalla NS, Kardami E. Basic fibroblast growth factor is cardioprotective in ischemia-reperfusion injury. Mol Cell Biochem. 1995; 143:129-135.
41. Liu L, Doble BW, Kardami E. Perinatal phenotype and hypothyroidism are associated with elevated levels of 21.5- to 22- kDa basic fibroblast growth factor in cardiac ventricles. Dev Biol. 1993;157:507-516.
42. Kaye D, Pimental D, Prasad S, Mäki T, Berger H-J, McNeil PL, Smith TW, Kelly RA. Role of transiently altered sarcolemmal membrane permeability and basic fibroblast growth factor release in the hypertrophic response of adult rat ventricular myocytes to increased mechanical activity in vitro. J Clin Invest. 1997;97:281-291.
43. Goto F, Goto K, Weindel K, Folkman J. Synergistic effects of vascular endothelial growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab Invest. 1993;69: 508-517.
44. Jonca F, Ortéga N, Gleizes P-E, Bertrand N, Plouët J. Cell release of bioactive fibroblast growth factor 2 by exon 6-encoded sequence of vascular endothelial growth factor. J Biol Chem. 1997;272:24203-24209.